Information for Amylin
Page information·measured at build time
Technical and provenance information about Amylin. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Amylin |
|---|---|
| Default sort key | Amylin |
| Namespace | Article (main) |
| Page kind | Compound |
| Page length (source, bytes) | 5,795 |
| Rendered word count | 666 |
| Internal wiki links on the page | 14 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — compound |
| Maintenance banners | None |
| Indexing by robots | Allowed |
Edit history
| Page creator | TirzTaxonomist |
|---|---|
| Date of page creation | 28 August 2024 |
| Latest editor | DulaglutideDug |
| Date of latest edit | 15 July 2026 |
| Total number of edits | 37 |
| Total number of distinct authors | 28 |
| Minor edits | 11 |
| Automated (bot) edits | 1 |
| Recent number of edits (last 90 days) | 4 |
| Talk page posts | 7 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| TirzTaxonomist | 3 | 8.1% | GLP-1 receptor agonists and related compounds |
| CagriCass | 2 | 5.4% | GLP-1 receptor agonists and related compounds |
| SarcopeniaSefa | 2 | 5.4% | adverse effects and clinical safety |
| IcodecIndra | 2 | 5.4% | GLP-1 receptor agonists and related compounds |
| LiraLotte | 2 | 5.4% | GLP-1 receptor agonists and related compounds |
| TrialsTabitha | 2 | 5.4% | clinical trials and evidence appraisal |
| AnalyticalAnnie | 2 | 5.4% | analytical chemistry and chromatography |
| CuriousCallum | 2 | 5.4% | GLP-1 receptor agonists and related compounds |
| StyleSheetSybil | 1 | 2.7% | copy-editing and the manual of style |
| SemaglutideSasha | 1 | 2.7% | GLP-1 receptor agonists and related compounds |
| SurvodutideSaff | 1 | 2.7% | GLP-1 receptor agonists and related compounds |
| UnitsUrsula | 1 | 2.7% | dosing, titration and injection practice |
Category membership
- Category:Amylin analogues — 4 member pages
- Category:Peptide drugs — 17 member pages
- Category:Incretin biology — 14 member pages